FR / EN / JP
spaceshot grant

Kevin Alessandri, CEO/CTO of TreeFrog was cited in a recent article of Labiotech.eu on the current obstacles preventing cell therapies to become mainstream. Read more...

29 May, 2019

TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporationFunding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapiesBordeaux, France, May 13, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that it has...

13 May, 2019

C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that...

15 April, 2019

https://youtu.be/b7y8YHiqlNI“Four months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office Aquitaine Science Transfert to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the ENSTBB, on the campus of Bordeaux, the start-up aims at providing the pharmaceutical industry with...

25 March, 2019